Free Trial

Exagen (XGN) Short Interest Ratio & Short Volume

$2.01
-0.02 (-0.99%)
(As of 07/26/2024 ET)

Exagen Short Interest Data

Current Short Interest
29,100 shares
Previous Short Interest
37,400 shares
Change Vs. Previous Month
-22.19%
Dollar Volume Sold Short
$57,618.00
Short Interest Ratio
0.8 Days to Cover
Last Record Date
July 15, 2024
Outstanding Shares
17,370,000 shares
Float Size
8,470,000 shares
Short Percent of Float
0.34%
Today's Trading Volume
11,501 shares
Average Trading Volume
25,576 shares
Today's Volume Vs. Average
45%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Exagen ?

Sign up to receive the latest short interest report for Exagen and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

XGN Short Interest Over Time

XGN Days to Cover Over Time

XGN Percentage of Float Shorted Over Time

Exagen Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202429,100 shares $57,618.00 -22.2%0.3%0.8 $1.98
6/30/202437,400 shares $68,068.00 +67.7%0.4%1.1 $1.82
6/15/202422,300 shares $43,708.00 -7.5%0.3%0.6 $1.96
5/31/202424,100 shares $46,995.00 -14.8%0.3%0.5 $1.95
5/15/202428,300 shares $54,053.00 +573.8%0.3%0.6 $1.91
4/30/20244,200 shares $5,754.00 -64.7%0.1%0.1 $1.37
4/15/202411,900 shares $17,017.00 -42.0%0.2%0.3 $1.43
3/31/202420,500 shares $32,595.00 +294.2%0.3%0.5 $1.59
3/15/20245,200 shares $8,424.00 +20.9%0.1%0.1 $1.62
2/29/20244,300 shares $9,675.00 -35.8%0.1%0.1 $2.25
2/15/20246,700 shares $14,137.00 -39.1%0.1%0.1 $2.11
1/31/202411,000 shares $23,650.00 +32.5%0.1%0.2 $2.15
1/15/20248,300 shares $16,600.00 -65.7%0.1%0.2 $2.00
12/31/202324,200 shares $48,158.00 +633.3%0.3%0.5 $1.99
12/15/20233,300 shares $5,115.00 -65.6%0.0%0.1 $1.55
11/30/20239,600 shares $18,048.00 +28.0%0.1%0.3 $1.88
11/15/20237,500 shares $11,586.00 +4.2%0.1%0.4 $1.54
10/31/20237,200 shares $11,808.00 +24.1%0.1%0.6 $1.64
10/15/20235,800 shares $10,904.00 -45.3%0.1%0.4 $1.88
9/30/202310,600 shares $25,652.00 -14.5%0.1%0.7 $2.42
9/15/202312,400 shares $30,132.00 +27.8%0.2%0.8 $2.43
8/31/20239,700 shares $24,444.00 -17.8%0.1%0.6 $2.52
8/15/202311,800 shares $29,500.00 +81.5%0.1%0.8 $2.50
7/31/20236,500 shares $15,990.00 -38.7%0.1%0.3 $2.46
7/15/202310,600 shares $28,620.00 +39.5%0.1%0.6 $2.70
6/30/20237,600 shares $22,040.00 +8.6%0.1%0.5 $2.90
6/15/20237,000 shares $22,540.00 -42.2%0.1%0.4 $3.22
5/31/202312,100 shares $36,421.00 +72.9%0.1%0.6 $3.01
5/15/20237,000 shares $20,370.00 -54.6%0.1%0.3 $2.91
4/30/202315,400 shares $39,116.00 +75.0%0.2%0.9 $2.54
4/15/20238,800 shares $21,384.00 +8.6%0.1%0.5 $2.43
3/31/20238,100 shares $19,683.00 -16.5%0.1%0.4 $2.43
3/15/20239,700 shares $22,989.00 -54.9%0.1%0.4 $2.37
2/28/202321,500 shares $54,825.00 +32.7%0.2%0.8 $2.55
2/15/202316,200 shares $40,824.00 -22.1%0.2%0.3 $2.52
1/31/202320,800 shares $59,072.00 -64.0%0.2%0.2 $2.84
1/15/202357,800 shares $167,042.00 -20.4%0.6%0.6 $2.89
12/30/202272,600 shares $174,240.00 -30.1%0.7%0.8 $2.40
12/15/2022103,900 shares $257,672.00 +3.5%1.1%1.1 $2.48
11/30/2022100,400 shares $271,080.00 +666.4%1.0%1.1 $2.70
Get out of cash before the Fed's next meeting (Ad)

"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."

Click here now to watch this exclusive interview
11/15/202213,100 shares $39,169.00 -34.8%0.1%0.2 $2.99
10/31/202220,100 shares $49,245.00 -33.7%0.2%0.7 $2.45
10/15/202230,300 shares $73,629.00 -14.2%0.3%1.6 $2.43
9/30/202235,300 shares $95,663.00 +18.5%0.4%1.6 $2.71
9/15/202229,800 shares $141,252.00 -18.4%0.3%0.7 $4.74
8/31/202236,500 shares $165,345.00 -5.7%0.4%0.8 $4.53
8/15/202238,700 shares $195,435.00 -14.8%0.4%0.7 $5.05
7/31/202245,400 shares $335,506.00 -25.2%0.5%0.8 $7.39
7/15/202260,700 shares $449,180.00 -23.7%0.7%0.9 $7.40
6/30/202279,600 shares $456,904.00 -79.5%0.9%1.2 $5.74
6/15/2022387,600 shares $2.37 million -4.1%4.2%6 $6.12
5/31/2022404,100 shares $2.02 million +5.0%4.4%8.6 $5.00
5/15/2022384,800 shares $1.86 million +9.6%4.2%8.6 $4.83
4/30/2022351,000 shares $2.14 million +73.3%3.8%8.6 $6.10
4/15/2022202,600 shares $1.28 million +0.5%2.2%5.7 $6.31
3/31/2022201,700 shares $1.62 million +23.4%2.2%5.9 $8.03
3/15/2022163,400 shares $1.30 million +16.8%1.8%5.2 $7.98
2/28/2022139,900 shares $1.06 million +18.1%1.5%3.9 $7.60
2/15/2022118,500 shares $1.03 million +21.8%1.3%3.3 $8.65
1/31/202297,300 shares $956,459.00 +49.0%1.1%2.7 $9.83
1/15/202265,300 shares $593,577.00 -2.1%0.7%1.8 $9.09
12/31/202166,700 shares $775,721.00 -0.3%0.8%1.9 $11.63
12/15/202166,900 shares $602,100.00 -21.9%0.8%2.1 $9.00
11/30/202185,700 shares $880,996.00 -1.7%0.9%2 $10.28
11/15/202187,200 shares $1.11 million -77.7%0.9%1.9 $12.68
10/29/2021390,900 shares $4.54 million -1.7%4.2%6.2 $11.62
10/15/2021397,600 shares $5.02 million -4.7%4.3%6.3 $12.63
9/30/2021417,000 shares $5.67 million -0.9%4.5%6.2 $13.60
9/15/2021420,800 shares $5.84 million -4.9%4.5%5 $13.87
8/31/2021442,400 shares $6.24 million +3.5%4.6%5.7 $14.10
8/13/2021427,600 shares $5.25 million -1.0%4.5%5.8 $12.28
7/30/2021431,800 shares $5.15 million +0.5%4.3%6.2 $11.92
7/15/2021429,800 shares $5.98 million -4.7%4.3%7 $13.92
6/30/2021451,000 shares $6.76 million +23.0%4.5%6.2 $14.99
6/15/2021366,600 shares $6.14 million +0.2%3.7%5.3 $16.75
5/28/2021365,800 shares $5.21 million +5.0%3.6%4.8 $14.25
5/14/2021348,400 shares $4.32 million +51.1%3.5%4.5 $12.40
4/30/2021230,600 shares $3.87 million +1.9%3.0%3.1 $16.80
4/15/2021226,400 shares $3.78 million +139.3%3.1%3.3 $16.69
3/31/202194,600 shares $1.65 million -12.6%1.4%1.6 $17.42
3/15/2021108,200 shares $2.17 million -15.3%2.0%2.2 $20.02
2/26/2021127,700 shares $2.46 million +4.1%2.4%3.9 $19.24
2/12/2021122,700 shares $2.25 million +12.1%2.3%4.5 $18.35
1/29/2021109,500 shares $1.78 million -4.7%2.1%4.1 $16.28
1/15/2021114,900 shares $1.69 million -3.2%2.2%5 $14.68
12/31/2020118,700 shares $1.43 million -13.1%2.3%6.3 $12.08
12/15/2020136,600 shares $1.76 million +10.2%2.7%10.9 $12.90
11/30/2020124,000 shares $1.83 million -2.7%2.5%11.8 $14.75
10/30/2020140,200 shares $2.03 million -1.7%2.8%7.4 $14.49
10/15/2020142,600 shares $2.12 million +1.3%2.9%5.7 $14.89
Get out of cash before the Fed's next meeting (Ad)

"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."

Click here now to watch this exclusive interview

XGN Short Interest - Frequently Asked Questions

What is Exagen's current short interest?

Short interest is the volume of Exagen shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 29,100 shares of XGN short. 0.34% of Exagen's shares are currently sold short. Learn More on Exagen's current short interest.

What is a good short interest ratio for Exagen?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XGN shares currently have a short interest ratio of 1.0. Learn More on Exagen's short interest ratio.

What is a good short interest percentage for Exagen?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.34% of Exagen's floating shares are currently sold short.

Is Exagen's short interest increasing or decreasing?

Exagen saw a decline in short interest in the month of July. As of July 15th, there was short interest totaling 29,100 shares, a decline of 22.2% from the previous total of 37,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Exagen's float size?

Exagen currently has issued a total of 17,373,000 shares. Some of Exagen's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Exagen currently has a public float of 8,470,000 shares.

How does Exagen's short interest compare to its competitors?

0.34% of Exagen's shares are currently sold short. Here is how the short interest of companies compare to Exagen: Burning Rock Biotech Limited (0.49%), Enzo Biochem, Inc. (1.65%), Renalytix Plc (3.95%), Psychemedics Co. (0.18%), BioNexus Gene Lab Corp. (2.85%), OpGen, Inc. (0.98%), Aclarion, Inc. (2.21%), DermTech, Inc. (9.50%), Fresh2 Group Limited (1.80%), Invitae Co. (26.15%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.

What does it mean to sell short Exagen stock?

Short selling XGN is an investing strategy that aims to generate trading profit from Exagen as its price is falling. XGN shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Exagen?

A short squeeze for Exagen occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of XGN, which in turn drives the price of the stock up even further.

How often is Exagen's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XGN, twice per month. The most recent reporting period available is July, 15 2024.



This page (NASDAQ:XGN) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners